ASND stock news · Ascendis Pharma

Stories about Ascendis Pharma (ASND) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for ASND

Follow Ascendis Pharma (ASND) free. When we publish a story about it, you get the plain-English explanation as an alert.

Free on the App Store and Google Play, or on the web.

Nov 6, 2026, 12:14 PM ET · Market
Ascendis Pharma will share its third quarter 2026 financial results on November 12, 2026.
Neutral
Ascendis Pharma set November 12, 2026, for its third-quarter report and business update. This announces timing, not results, so it does not change the company's outlook.
Aug 13, 2026, 9:46 AM ET · Results
Ascendis Pharma Q2 2026 Earnings Call Complete Transcript Available.
Good for ASND
Ascendis Pharma's Q2 2026 earnings call revealed a doubling of product revenue year-over-year, driven by strong sales of Yorvipath, which achieved blockbuster status. The company is optimistic about future growth, projecting revenues to reach 5 billion euro by 2030, supported by strategic initiatives and a solid financial position.